BS Nursing Pharmacology-I
nmdcat.online June 6, 2026

40. A patient with Type 2 Diabetes is prescribed empagliflozin. Clinically, what is the primary mechanism of action of this drug?

A. Increasing insulin secretion.
B. Decreasing hepatic glucose production.
C. Inhibiting sodium-glucose co-transporter 2 (SGLT2) in the kidneys, leading to increased glucose excretion.
D. Enhancing insulin sensitivity.

📖 Additional Information

  • Increasing insulin secretion.
  • Decreasing hepatic glucose production.
  • Inhibiting sodium-glucose co-transporter 2 (SGLT2) in the kidneys, leading to increased glucose excretion.
  • Enhancing insulin sensitivity.

🔗 Share This Question

Categories

View all →